États-Unis · Magazines éco · Quartz

Lycia Therapeutics stock surges in IPO debut after pricing about $317.5M offering

Publié par Quartz · États-Unis il y a 2 h

The drug developer priced 17.64 million shares at $18 each, and the offering is expected to close on Oct. 26

Lire l'article complet sur Quartz Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (qz.com)

À lire aussi

Do These 5 Things Before You Pitch an Investor

An $8 billion Treasury break helped bring Meta’s tax rate to 2%. Now it has a week to answer senators about data center tax credits

Why pet owners are struggling to afford veterinary care

Markets Insider (Business Insider)

Oregon Bancorp GAAP EPS of $0.30, revenue of $4.87M

9 Changes to Social Security in 2027

AI's Next Big Business Model: The Great Surprise Of Meta's Muse